Very early recurrence of anti-phospholipase A 2 receptor-positive membranous nephropathy after transplantation

American Journal of Transplantation

Volumn 12, Issue 6, 2012, Pages 1637-1642

  Blosser, C D ^a   Ayalon, R ^b   Nair, R ^a   Thomas, C ^a   Beck Jr , L H ^b  

^a UNIVERSITY OF IOWA   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anti PLA 2R autoantibody; kidney transplant; Phospholipase A 2 Receptor; recurrent membranous nephropathy

Indexed keywords

BASILIXIMAB; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CREATININE; CYCLOPHOSPHAMIDE; GLUCOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOSARTAN; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEGA 3 FATTY ACID; PHOSPHOLIPASE A2 RECEPTOR; PREDNISONE; PROTEIN; TACROLIMUS;

ADULT; ALLELE; ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; GENOTYPE; GLUCOSE URINE LEVEL; HEMODIALYSIS; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; OLIGURIA; PH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RECURRENT DISEASE; URINALYSIS; URINE VOLUME; WESTERN BLOTTING;

AUTOANTIBODIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; RECURRENCE;

EID: 84861809009     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03957.x     Document Type: Article

References (15)

1. Cattran D,. Management of membranous nephropathy: When and what for treatment. J Am Soc Nephrol (JASN) 2005; 16: 1188-1194.
2. El-Zoghby ZM, Grand JP, Fraile MG, et al,. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant (official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons) 2009; 9: 2800-2807.
3. Sprangers B, Lefkowitz GI, Cohen SD, et al,. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation. Clin J Am Soc Nephrol (CJASN) 2010; 5: 790-797.
4. Beck LH Jr, Bonegio RG, Lambeau G, et al,. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21.
5. Debiec H,. Ronco PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011; 364: 689-690.
6. Beck LH Jr, Fervenza FC, Beck DM, et al,. Rituximab-induced depletion of anti-pla2r autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol (JASN) 2011; 22: 1543-1550.
7. Stanescu HC, Arcos-Burgos M, Medlar A, et al,. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364: 616-626.
8. Romanos J, Wijmenga C,. Comment on: Barker et al. 2008. Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: Diabetes 57:3152-3155, 2008. Diabetes 2009; 58: e1; author reply e2.
9. Glassock RJ,. Human idiopathic membranous nephropathy-a mystery solved? N Engl J Med 2009; 361: 81-83.
10. Stahl R, Hoxha E, Fechner K,. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 2010; 363: 496-498.
11. Debiec H, Martin L, Jouanneau C, et al,. Autoantibodies specific for the Phospholipase A(2) receptor in recurrent and De Novo membranous nephropathy. Am J Transplant (official journal of the American Society of Transplantation and the American Society of Transplant Surgeons) 2011; 11: 2144-2151.
12. Makker SP, Kanalas JJ,. Course of transplanted Heymann nephritis kidney in normal host. Implications for mechanism of proteinuria in membranous glomerulonephropathy. J Immunol 1989; 142: 3406-3410.
13. Ruggenenti P, Cravedi P, Sghirlanzoni MC, et al,. Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. Clin J Am Soc Nephrol (CJASN) 2008; 3: 1652-1659.
14. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ,. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (CJASN) 2011; 6: 1286-1291.
15. Cosyns JP, Pouteil-Noble C, Squifflet JP, Pirson Y,. Recurrence of membranous nephropathy after renal transplantation: Probability, outcome and risk factors. Clin Nephrol 1998; 50: 144-153.